Recent Articles

• 
  Medical / Research

  Korean Team First to Map Assembly of Disease-Blocking Protein Complex

  Kim V. Narry, director of the RNA Research Center at the Institute for Basic Science (IBS). Provided by IBS The prospects are improving for more precise design of ribonucleic acid (RNA) therapeutics to treat intractable diseases caused by gene overexpression, following the elucidation of the formati

  2026.06.12
• 
  AI Healthcare

  SNU Professor Lee Jaesung Wins First Asian Hoffman Memorial Prize

  Lee Jae-sung, professor at Seoul National University College of Medicine. Courtesy of SNU On the 11th, Seoul National University (SNU) announced that Professor Lee Jae-sung of SNU College of Medicine and the Interdisciplinary Program for Advanced Convergence has been selected as the recipient of the

  2026.06.12
• 
  Vaccine

  GC Pharma Unveils mRNA Platform, Preps COVID Vaccine Trial

  Panoramic view of GC Green Cross headquarters. Provided by GC Green Cross GC Green Cross is pushing ahead with the development of a COVID-19 vaccine based on its self-developed mRNA-LNP platform. The company is targeting submission of a phase 2 clinical trial plan in the second half of this year.GC

  2026.06.11
• 
  DTx / Platform

  IlDong Pharma, Welt Partner on Digital Convergence Drug

  IlDong Pharmaceutical CEOs Yoon Woong-seop (right) and Lee Jae-joon (left) pose for a commemorative photo after signing a business agreement with Kang Sung-ji, CEO of WELT. IlDong Pharmaceutical is promoting the development of “digital convergence pharmaceuticals” designed to enhance patients’ medic

  2026.06.11
• 
  AI Healthcare

  Check ‘Heart Age’ in 30 Seconds: New Home-Care, Fitness Devices Draw Attention

  On the morning of the 11th, citizens experience home-training products such as indoor exercise bikes and steppers. Photo by reporter Shin Won-gun laputa@donga.com On the final day of the “2026 Seoul Health Show,” held at Seoul Plaza in Jung-gu, Seoul on the 11th, a steady stream of visitors came to

  2026.06.11
• 
  Samsung

  Samsung Becomes Top Shareholder in US Element, Speeds Medtech Commercialization

  Samsung Electronics has become the largest shareholder of Element Biosciences (Element), a U.S. gene analysis equipment company. The move is part of an expansion of its “medtech (medical technology and devices)” business, which was identified as a future growth engine under the late Chairman Lee Kun

  2026.06.11
• 
  Medical / Research

  Younger Women With Stomach Cancer Have Lower Survival

  Professor Kim Na-young (left) and Professor Choi Yong-hoon of the Division of Gastroenterology, Seoul National University Bundang Hospital. Courtesy of Seoul National University Bundang Hospital The survival rate of women under the age of 50 with gastric cancer has been found to be lower than that o

  2026.06.10
• 
  Pharmaceutical R&D

  ‘We’ll Help Advance Korea’s Bio Sovereignty’

  Jeong Hee-jin, Head of the Vaccine Innovation Center Jeong Hee-jin, head of the Vaccine Innovation Center at Korea University College of Medicine (professor of infectious diseases at Korea University Guro Hospital), said, “Through cooperation with the government, research institutes, and industry, I

  2026.06.10
• 
  Pharmaceutical R&D

  From Outcomes to Data Science: Drug Trials Evolve

  최근 신약 개발 환경이 빠르게 변화하면서 임상시험에서 데이터관리(DM)와 통계분석(STAT)의 중요성이 더욱 부각되고 있다. 임상시험은 과거 환자 치료 결과를 중심으로 평가되던 ‘클리니컬 사이언스’ 영역에서 이제는 데이터를 기반으로 의사결정을 내리는 ‘데이터 사이언스’ 중심으로 전환되고 있다. 동시에 글로벌 규제 기관의 요구 수준이 높아지고 다국가·대규모 임상이 증가하면서 방대한 데이터를 얼마나 정확하고 일관되게 관리하고 해석하느냐가 신약 개발의 핵심 경쟁력으로 자리 잡고 있다. 이처럼 임상시험의 패러다임이 ‘데이터 중심’으로 재편

  2026.06.10
• 
  Pharmaceutical R&D

  Korean Team Discovers New Agent for Resistant Metastatic Cancer

  From left: Professor Park Ki-cheong, Department of Surgery, Yonsei University College of Medicine; Professor Lim Jin-hong, Division of Hepatobiliary and Pancreatic Surgery, Gangnam Severance Hospital; and Professor Choi Kyung-hwa, Bundang CHA Hospital. A Korean bio company, Therapeutics NMC, and a j

  2026.06.10